tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology Financial Overview

Elevation Oncology's market cap is currently ―. The company's EPS TTM is $-0.807; its P/E ratio is ―; Elevation Oncology is scheduled to report earnings on May 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -45.45M$ -94.55M$ -32.05M$ -17.28M$ -5.88M
EBITDA$ -41.44M$ -93.53M$ -32.02M$ -17.26M$ -5.88M
Net Income$ -45.70M$ -95.08M$ -32.04M$ -17.27M$ -5.88M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 89.09M$ 94.16M$ 149.49M$ 80.91M$ 1.91M
Total Debt$ 30.14M$ 29.43M$ 0.00$ 0.00$ 0.00
Net Debt$ -52.97M$ -60.84M$ -146.28M$ -79.40M$ -1.74M
Total Liabilities$ 34.28M$ 45.13M$ 8.80M$ 103.99M$ 7.79M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -56.18M$ -85.57M$ -30.17M$ -12.37M$ -5.45M
Operating Cash Flow$ -56.18M$ -85.48M$ -30.17M$ -12.30M$ -5.45M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Elevation Oncology Earnings and Revenue History

Elevation Oncology Debt to Assets

Elevation Oncology Cash Flow

Elevation Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis